MedTrace Logo

Cardiac Amyloidosis Registry Study

NCT05174338 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-09-06

No results posted yet for this study

Summary

This registry is a observational, multi-center study designed to collect data and analyze it retrospectively on patients with cardiac amyloidosis who have been evaluated and treated at major amyloid centers across the US and internationally between 1997 and 2025.

Conditions

  • Amyloidosis, Immunoglobulin Light-chain

Interventions

OTHER

Registry

Observational, data collection

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-08
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05174338 on ClinicalTrials.gov